BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 13489165)

  • 21. Effect of serotonin on phenol oxidase from the liver fluke Fasciola hepatica and from other sources.
    MANSOUR TE
    Biochim Biophys Acta; 1958 Dec; 30(3):492-500. PubMed ID: 13618254
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of intraventricular injection of d-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat.
    BRADLEY PB; HANCE AJ
    J Physiol; 1956 May; 132(2):50-1P. PubMed ID: 13320431
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex.
    BULBRING E; CREMA A
    Br J Pharmacol Chemother; 1958 Dec; 13(4):444-57. PubMed ID: 13618550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Hydroxytryptamine antagonism by lysergic acid diethylamide after intracerebral injection in conscious mice.
    HALEY TJ
    J Am Pharm Assoc Am Pharm Assoc; 1957 Jul; 46(7):428-30. PubMed ID: 13491414
    [No Abstract]   [Full Text] [Related]  

  • 26. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on guppy Poecilia reticulatus chromatophores].
    CERLETTI A; BERDE B
    Experientia; 1955 Aug; 11(8):312-3. PubMed ID: 13262009
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of substance P by lysergic acid diethvlamide in vivo.
    KRIVOY WA
    Br J Pharmacol Chemother; 1961 Jun; 16(3):253-6. PubMed ID: 13754427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The action of 5-hydroxytryptamine and some of its antagonists on the umbilical vessels of the human placenta.
    ASTROM A; SAMELIUS U
    Br J Pharmacol Chemother; 1957 Dec; 12(4):410-4. PubMed ID: 13489166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.
    DOEPFNER W; CERLETTI A
    Int Arch Allergy Appl Immunol; 1958; 12(1-2):89-97. PubMed ID: 13549054
    [No Abstract]   [Full Text] [Related]  

  • 34. Electroencephalographic effects of intraventricular 5-HT and LSD in the cat.
    VOGT M; GUNN CG; SAWYER CH
    Neurology; 1957 Aug; 7(8):559-66. PubMed ID: 13451892
    [No Abstract]   [Full Text] [Related]  

  • 35. The antagonism of the vascular effects of 5-hydroxytryptamine by BOL 148 and sodium salicylate in the human subject.
    GLOVER WE; MARSHALL RJ; WHELAN RF
    Br J Pharmacol Chemother; 1957 Dec; 12(4):498-503. PubMed ID: 13489181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Eur J Pharmacol; 1977 Oct; 45(4):341-8. PubMed ID: 923645
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockade of depressor responses to serotonin and tryptamine by lysergic acid derivatives in the chicken.
    BUNAG RD; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():142-51. PubMed ID: 13874645
    [No Abstract]   [Full Text] [Related]  

  • 38. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 5-hydroxytryptamine on the respiration of excised lamellibranch gill.
    MOORE KE; MILTON AS; GOSSELIN RE
    Br J Pharmacol Chemother; 1961 Oct; 17(2):278-85. PubMed ID: 14475689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.